Adverse Event Reporting and Standardized Medical Terminologies: Strengths and Limitations
- 1 April 2002
- journal article
- other
- Published by Springer Nature in Drug Information Journal
- Vol. 36 (2) , 439-444
- https://doi.org/10.1177/009286150203600224
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Tabulation and analysis of pharmacovigilance data using the medical dictionary for regulatory activitiesPharmacoepidemiology and Drug Safety, 2000
- The Medical Dictionary for Regulatory Activities (MedDRA)Drug Safety, 1999
- A Preliminary Assessment of the Impact of Meddra on Adverse Event Reports and Product LabelingDrug Information Journal, 1998
- Harmonising Adverse Drug Reaction TerminologyDrug Safety, 1998
- Lithium and Neuroleptics in Combination: Is There Enhancement of Neurotoxicity Leading to Permanent Sequelae?The Journal of Clinical Pharmacology, 1996
- The FDA's Medical Dictionary for Drug Regulatory Affairs Alpha TestDrug Information Journal, 1995
- Terminology in prescription-event monitoringEuropean Journal of Clinical Pharmacology, 1994
- The medical dictionary for drug regulatory affairs (MEDDRA) projectPharmacoepidemiology and Drug Safety, 1994
- Neuroleptic malignant syndromeMedical Clinics of North America, 1993
- Symptoms of neuroleptic malignant syndrome in 82 consecutive inpatientsAmerican Journal of Psychiatry, 1986